Serial Number | 79275472 |
Word Mark | ACAZEN |
Filing Date | Thursday, November 21, 2019 |
Status | 700 - REGISTERED |
Status Date | Tuesday, January 26, 2021 |
Registration Number | 6253453 |
Registration Date | Tuesday, January 26, 2021 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 10, 2020 |
Goods and Services | Nutritional supplements for medical use; medicines, particularly phytopharmaceutical products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); active plant agents and plant extracts for medical use, namely, plant extracts for pharmaceutical purposes; pharmaceutical, veterinary and sanitary products, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); dietetic substances in the nature of food and beverages for medical use, food for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical use, namely, biological preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical products for medical use, namely, chemical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical products, namely, chemical-pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for dental use, namely, medicines for treating dentalirritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); medicines for human medicine, namely, pharmaceutical preparations for treating irritable bowel syndrome, constipation, diarrhoea, inflammatory bowel disease, coeliac disease, intolerance to FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols); radiological contrast substances for medical use; steroids |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 8, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Alpinia Institute for Life Sciences AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Party Name | Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 25 - NOT AVAILABLE |
Address | CH |
Event Date | Event Description |
Monday, June 7, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Saturday, May 15, 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Friday, April 30, 2021 | GENERIC MADRID TRANSACTION SENT TO IB |
Thursday, April 29, 2021 | GENERIC MADRID TRANSACTION CREATED |
Monday, April 26, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, January 26, 2021 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, November 10, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, November 10, 2020 | PUBLISHED FOR OPPOSITION |
Sunday, November 8, 2020 | NOTIFICATION PROCESSED BY IB |
Wednesday, October 21, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, October 21, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, October 21, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, October 6, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, October 6, 2020 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, October 6, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, October 6, 2020 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, October 6, 2020 | EXAMINERS AMENDMENT -WRITTEN |
Friday, September 25, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, September 24, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, September 24, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, April 10, 2020 | REFUSAL PROCESSED BY IB |
Tuesday, March 24, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, March 24, 2020 | REFUSAL PROCESSED BY MPU |
Wednesday, March 4, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, March 3, 2020 | NON-FINAL ACTION WRITTEN |
Tuesday, February 25, 2020 | ASSIGNED TO EXAMINER |
Tuesday, January 14, 2020 | APPLICATION FILING RECEIPT MAILED |
Wednesday, January 8, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, January 2, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |